Transgene

Transgene is a biotechnology company focused on the clinical research and development of immunotherapeutic products and therapeutic vaccines aimed at treating cancers and chronic infectious diseases. The company is involved in all stages of product development, from research and manufacturing to conducting clinical trials. Its clinical-stage programs include TG4010 for non-small cell lung cancer and Pexa-vec for liver cancer, along with a diverse pipeline featuring products such as TG4001, TG1050, and TG6002. Most of Transgene's operations are based in France, where it leverages its expertise to advance innovative treatments in the biopharmaceutical sector.